News

Published on 28 Oct 2021 on Zacks via Yahoo Finance

Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates


Article preview image

Baxter International Inc. BAX reported third-quarter 2021 adjusted earnings per share (EPS) of $1.02, which outpaced the Zacks Consensus Estimate of 94 cents by 8.5%. The bottom line improved 22.9% from the year-ago quarter.GAAP EPS in the quarter was 89 cents, up 29% from the prior-year quarter.

Revenue Details

Revenues of $3.23 billion surpassed the Zacks Consensus Estimate by 0.1%. The top line improved 8.5% year over year on a reported basis, 7% on a constant currency (cc) basis and 6% on an operational basis.

NYSE.ABT price evolution
NYSE.DGX price evolution
NYSE.BAX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Abbott Laboratories (NYSE:ABT) is largely controlled by institutional...

Ownership Tell Us About Abbott Laboratories? Institutions typically measure themselves against a...

Simply Wall St. · via Yahoo Finance 24 Nov 2024

2 Dividend Kings to Buy for a Lifetime of Passive Income

Dividend Kings are among the best income stocks on the market. Let's consider two companies in th...

Motley Fool · via Yahoo Finance 22 Nov 2024

Major companies that are also popular short-selling stocks

Investor confidence in certain major companies has propelled markets higher, but there are also...

Yahoo Finance UK 21 Nov 2024

DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring

So the companies are seeing if Type-2 diabetes patients and health-conscious folks will pay...

Barrons.com 20 Nov 2024

Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise

Medtronic stock slumped Tuesday despite beating fiscal second-quarter expectations after a suppli...

Investor's Business Daily 19 Nov 2024

Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now

We recently compiled a list of the 8 Magnificent Dividend Growth Stocks to Buy Now. In this artic...

Insider Monkey · via Yahoo Finance 17 Nov 2024

Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment

AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stag...

Insider Monkey · via Yahoo Finance 16 Nov 2024

Dividend King AbbVie Just Paid Investors: Here's How Much They Got

AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of...

247wallst.com 16 Nov 2024

Abbott extends executive agreements through 2026 By Investing.com

Abbott Laboratories (NYSE:ABT), a key player in the pharmaceutical industry, has announced the...

Investing.com 15 Nov 2024

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100...

Its dividend yields 3%, and if your priority is to generate a safe and recurring dividend, Coca-C...

Motley Fool · via Yahoo Finance 14 Nov 2024